Mackay Shields’s MyoKardia MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-19,300
Closed -$2.63M – 1648
2020
Q3
$2.63M Buy
19,300
+9,400
+95% +$999K 0.02% 674
2020
Q2
$956K Buy
+9,900
New +$826K 0.01% 1033

Mackay Shields's MYOK Position: Q4 2020 in Review

Mackay Shields sold out of MyoKardia (MYOK) in Q4 2020, closing a stake of 19,300 shares — an estimated $2.63M sold.

Mackay Shields first reported a position in MYOK in Q2 2020 and held it in 2 quarters. The position peaked at $2.63M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Mackay Shields reported no remaining MyoKardia position as of Q4 2020 after selling out during the quarter.
  • Mackay Shields sold 19,300 MyoKardia shares in Q4 2020, an estimated $2.63M.
  • Mackay Shields first reported a position in MyoKardia in Q2 2020 and held it in 2 quarters.
  • Mackay Shields's MyoKardia position peaked at $2.63M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia as of Q4 2020.

Based on Mackay Shields's 13F filing for Q4 2020, filed 16 Feb 2021.